RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Day One Biopharmaceuticals Stock

Day One Biopharmaceuticals Equity 2024

Day One Biopharmaceuticals Equity

346.54 M USD

Ticker

DAWN

ISIN

US23954D1090

In 2024, Day One Biopharmaceuticals's equity was 346.54 M USD, a 4.38% increase from the 332 M USD equity in the previous year.

Day One Biopharmaceuticals Aktienanalyse

What does Day One Biopharmaceuticals do?

Day One Biopharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Day One Biopharmaceuticals's Equity

Day One Biopharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Day One Biopharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Day One Biopharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Day One Biopharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Day One Biopharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Day One Biopharmaceuticals stock

What is the equity of Day One Biopharmaceuticals this year?

Day One Biopharmaceuticals has equity of 346.54 M USD this year.

What was the equity of Day One Biopharmaceuticals compared to the previous year?

The equity of Day One Biopharmaceuticals has increased/decreased by 4.38% increased compared to the previous year.

What impact does a high equity have on investors of Day One Biopharmaceuticals?

A high equity is advantageous for investors of Day One Biopharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Day One Biopharmaceuticals?

A low equity can be a risk for investors of Day One Biopharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Day One Biopharmaceuticals affect the company?

An increase in equity of Day One Biopharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Day One Biopharmaceuticals affect the company?

A reduction in equity of Day One Biopharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Day One Biopharmaceuticals?

Some factors that can affect the equity of Day One Biopharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Day One Biopharmaceuticals so important for investors?

The equity of Day One Biopharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Day One Biopharmaceuticals take to change the equity?

To change equity, Day One Biopharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Day One Biopharmaceuticals pay?

Over the past 12 months, Day One Biopharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Day One Biopharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Day One Biopharmaceuticals?

The current dividend yield of Day One Biopharmaceuticals is .

When does Day One Biopharmaceuticals pay dividends?

Day One Biopharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Day One Biopharmaceuticals?

Day One Biopharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Day One Biopharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Day One Biopharmaceuticals located?

Day One Biopharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Day One Biopharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Day One Biopharmaceuticals from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Day One Biopharmaceuticals pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Day One Biopharmaceuticals in the year 2023?

In the year 2023, Day One Biopharmaceuticals distributed 0 USD as dividends.

In which currency does Day One Biopharmaceuticals pay out the dividend?

The dividends of Day One Biopharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Day One Biopharmaceuticals

Our stock analysis for Day One Biopharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Day One Biopharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.